Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Men"

10065 News Found

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment
Medical Device | June 03, 2026

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment

New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure


Virohan launches Rs. 2 crore scholarship to promote health education among women
Healthcare | June 03, 2026

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery
Hospitals | June 02, 2026

AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery

Real-time remote collaboration during robotic-assisted cholecystectomy showcases new possibilities for surgical mentoring, education, and knowledge sharing across institutions


Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
Drug Approval | June 02, 2026

Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma

The approval is supported by results from the Phase 3 SWOG 1826 trial


STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial
Clinical Trials | June 02, 2026

STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial

While overall survival data remain immature, the results pointed to a favourable trend.


Merck’s experimental cancer drug wins FDA breakthrough status in key lung cancer setting
Drug Approval | May 30, 2026

Merck’s experimental cancer drug wins FDA breakthrough status in key lung cancer setting

The designation marks the first Breakthrough Therapy recognition for calderasib and is backed by positive results from the Phase 1 KANDLELIT-001 clinical trial


Solvay and Pantys deepen partnership to expand menstrual health access
Public Health | May 29, 2026

Solvay and Pantys deepen partnership to expand menstrual health access

Solvay will fund Pantys-led initiatives targeting vulnerable communities through product donations and menstrual health education programs